Company intelligence / Profile preview

HighCape Capital Special Opportunities Fund

New York, New York, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

HighCape Capital Special Opportunities Fund is a life sciences-focused growth equity/special opportunities investment vehicle under HighCape Capital, backing commercial-stage and late-development companies rather than developing drugs or devices itself.[1][2][3]

Industry: Investors

Partnerships

Sponsor of HighCape Capital Acquisition Corp. (SPAC)[4][5]Business combination with Quantum-Si via HighCape Capital Acquisition Corp.[5]

Beyond the preview

Go deeper on HighCape Capital Special Opportunities Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HighCape Capital Special Opportunities Fund.

Explore the full profile